|
Market Closed -
Nasdaq
01:30:00 26/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 8.360 USD | -2.45% |
|
-7.73% | -71.03% |
| 15/09 | Capricor Therapeutics Shares Rise After Upgrade From B. Riley | MT |
| 14/09 | B. Riley Upgrades Capricor Therapeutics to Buy From Neutral, Raises Price Target to $21 From $5 | MT |
| Market Cap | 49Cr 43Cr 40Cr 37Cr 69Cr 4.66TCr 69Cr 482.03Cr 186.7Cr 2.38TCr 182.49Cr 178.54Cr 7.65TCr | P/E 2026 * |
-4.56x | P/E 2027 * | -5.61x |
|---|---|---|---|---|---|
| Enterprise Value | 49Cr 43Cr 40Cr 37Cr 69Cr 4.66TCr 69Cr 482.03Cr 186.7Cr 2.38TCr 182.49Cr 178.54Cr 7.65TCr | EV / Sales 2026 * |
8.73x | EV / Sales 2027 * | 8.6x |
| Free-Float |
90.56% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CAPR | Delayed | |
CBOE
| CAPR | Real-time | |
|
Boerse Muenchen
| 4LN2 | Real-time | |
|
Tradegate
| 4LN2 | Real-time | |
|
Börse Stuttgart
| 4LN2 | Delayed | |
|
Deutsche Boerse AG
| 4LN2 | Delayed |
Last Transcript: Capricor Therapeutics, Inc.
| 1 day | -2.45% | ||
| 1 week | -7.73% | ||
| Current month | -15.64% | ||
| 1 month | -10.68% | ||
| 3 months | -68.38% | ||
| 6 months | -72.09% | ||
| Current year | -71.03% |
| 1 week | 8.27 |  | 9.48 |
| 1 month | 8.18 | | 11 |
| Current year | 2.96 | | 36.82 |
| 1 year | 2.96 | | 40.37 |
| 3 years | 2.68 | | 40.37 |
| 5 years | 2.56 | | 40.37 |
| 10 years | 0.88 | | 42.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 62 | 20/11/2013 |
Anthony Bergmann
DFI | Director of Finance/CFO | 40 | 01/01/2018 |
Michael Binks
CTO | Chief Tech/Sci/R&D Officer | - | 13/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Litvack
CHM | Chairman | 70 | 01/11/2013 |
David Musket
BRD | Director/Board Member | 68 | 20/11/2013 |
George Dunbar
BRD | Director/Board Member | 79 | 20/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 26/05/26 | Free | CHIEF COMMERCIAL OFFICER | 80,000 | 0.1383% | ||
| 18/05/26 | Exercice | Chief Financial Officer | 6,000 | 0.0104% | ||
| 13/05/26 | Exercice | Chairman | 7,874 | 0.0136% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.45% | -7.73% | +17.91% | +46.15% | 49Cr | |
| -3.30% | +1.50% | +57.79% | +99.14% | 7.23TCr | |
| +1.25% | -3.01% | +37.83% | +87.66% | 6.02TCr | |
| +2.12% | +5.26% | +35.69% | +23.40% | 2.77TCr | |
| -3.06% | -1.81% | -14.01% | +357.24% | 2.57TCr | |
| -0.75% | +2.56% | +0.45% | -3.28% | 2.47TCr | |
| +0.40% | +0.75% | +23.72% | -11.33% | 2.07TCr | |
| -1.70% | -2.12% | +150.24% | +326.97% | 1.51TCr | |
| +0.36% | -0.34% | +48.98% | +167.40% | 1.44TCr | |
| +0.21% | +1.17% | -3.95% | +512.06% | 1.42TCr | |
| Average | -0.69% | -0.38% | +35.46% | +160.54% | 2.76TCr | |
| Weighted average by Cap. | -0.77% | +0.30% | +38.12% | +132.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.57Cr 4.89Cr 4.62Cr 4.21Cr 7.87Cr 533.76Cr 7.93Cr 55Cr 21Cr 272.69Cr 21Cr 20Cr 876.38Cr | 5.65Cr 4.96Cr 4.69Cr 4.27Cr 7.99Cr 541.89Cr 8.05Cr 56Cr 22Cr 276.84Cr 21Cr 21Cr 889.74Cr |
| Net income | -13Cr -12Cr -11Cr -9.97Cr -19Cr -1.27TCr -19Cr -130.9Cr -51Cr -646.27Cr -50Cr -48Cr -2.08TCr | -8.95Cr -7.85Cr -7.42Cr -6.76Cr -13Cr -857.9Cr -13Cr -89Cr -34Cr -438.28Cr -34Cr -33Cr -1.41TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/26/25 | $8.360 | -2.45% | 19,19,693 |
| 24/26/24 | $8.570 | -1.15% | 24,02,138 |
| 23/26/23 | $8.670 | -7.17% | 31,47,288 |
| 22/26/22 | $9.340 | +4.94% | 24,99,553 |
| 21/26/21 | $8.900 | -1.77% | 24,19,019 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CAPR Stock
Select your edition
All financial news and data tailored to specific country editions
